BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 25422156)

  • 1. Autophagy modulation: a target for cancer treatment development.
    Duffy A; Le J; Sausville E; Emadi A
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):439-47. PubMed ID: 25422156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.
    Chude CI; Amaravadi RK
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine in cancer therapy: a double-edged sword of autophagy.
    Kimura T; Takabatake Y; Takahashi A; Isaka Y
    Cancer Res; 2013 Jan; 73(1):3-7. PubMed ID: 23288916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer.
    Poklepovic A; Gewirtz DA
    Autophagy; 2014 Aug; 10(8):1478-80. PubMed ID: 24991829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis-modulating drugs for improved cancer therapy.
    Ocker M; Höpfner M
    Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular crosstalk between the proteasome, aggresomes and autophagy: translational potential and clinical implications.
    Driscoll JJ; Chowdhury RD
    Cancer Lett; 2012 Dec; 325(2):147-54. PubMed ID: 22781397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress of hydroxychloroquine and autophagy inhibitors on cancer.
    Shi TT; Yu XX; Yan LJ; Xiao HT
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):287-294. PubMed ID: 27889812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies.
    Bincoletto C; Bechara A; Pereira GJ; Santos CP; Antunes F; Peixoto da-Silva J; Muler M; Gigli RD; Monteforte PT; Hirata H; Jurkiewicz A; Smaili SS
    Chem Biol Interact; 2013 Nov; 206(2):279-88. PubMed ID: 24121004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy.
    Fong W; To KKW
    Recent Pat Anticancer Drug Discov; 2021; 16(2):204-221. PubMed ID: 33413069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
    Engel J; Emons G; Pinski J; Schally AV
    Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy therapeutics: preclinical basis and initial clinical studies.
    Zhan L; Li J; Wei B
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):923-934. PubMed ID: 30225602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.
    Ferreira PMP; Sousa RWR; Ferreira JRO; Militão GCG; Bezerra DP
    Pharmacol Res; 2021 Jun; 168():105582. PubMed ID: 33775862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia.
    Sehgal AR; Konig H; Johnson DE; Tang D; Amaravadi RK; Boyiadzis M; Lotze MT
    Leukemia; 2015 Mar; 29(3):517-25. PubMed ID: 25541151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of autophagy in cancer: therapeutic implications.
    Yang ZJ; Chee CE; Huang S; Sinicrope FA
    Mol Cancer Ther; 2011 Sep; 10(9):1533-41. PubMed ID: 21878654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress.
    Rahman MA; Saikat ASM; Rahman MS; Islam M; Parvez MAK; Kim B
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: A systematic review and meta-analysis.
    Xu R; Ji Z; Xu C; Zhu J
    Medicine (Baltimore); 2018 Nov; 97(46):e12912. PubMed ID: 30431566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of therapy-induced autophagy and necrosis in cancer treatment.
    Amaravadi RK; Thompson CB
    Clin Cancer Res; 2007 Dec; 13(24):7271-9. PubMed ID: 18094407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.